GlassScriptPhysician profile
Dorcas Poni Eshun
NPI 1295088854
$1,766.95
in general payments reported to CMS, 2019-2025
20 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $43.16 · 2024: $638 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,766.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $317.94 | 2024-2025 | |
| Verrica Pharmaceuticals INC. | $232.18 | 2023-2025 | Ycanth |
| Sanofi-Aventis U.S. LLC | $200.01 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $144.19 | 2024 | |
| Csl Behring | $121.59 | 2025 | Andembry |
| Merck Sharp & Dohme LLC | $118.43 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $110.56 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $96.02 | 2025 | Qelbree |
| Kaleo, INC. | $62.01 | 2024 | Auvi-Q |
| Alexion Pharmaceuticals, INC. | $52.31 | 2025 | Koselugo, Strensiq |
| Collegium Pharmaceutical, INC. | $52.28 | 2025 | Jornay Pm |
| Kowa Pharmaceuticals America, INC. | $50.38 | 2024-2025 | Zoryve |
| Ars Pharmaceuticals Operations, INC. | $41.55 | 2025 | Neffy |
| Cranial Technologies, INC | $36.23 | 2024-2025 | Doc Band |
| Seqirus USA INC | $25.67 | 2025 | Flucelvax |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $24.69 | 2025 | |
| Xeris Pharmaceuticals, INC. | $24.56 | 2025 | Gvoke Hypopen |
| Photonicare INC | $21.54 | 2025 | Otosight Middle Ear Scope |
| Phadia US INC. | $18.84 | 2025 | Immunocap |
| Lnhc, INC | $15.97 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dorcas Eshun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.